ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform incluiding issues related to the Part D program and those related to low income beneficiaries and protected medication classes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THERESA JOLIVETTE | — |
| JACQUELINE POMFRET KIRBY | — |
| JOHN MYERS | — |
| BELA SASTRY | — |
Health Issues HCR
Antibiotic Development to Advance Patient Treatment Act. Issues related to oncology legislation, including medication affordability. Issues related to 21st Century Cures legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARIA FIRVIDA | — |
| THERESA JOLIVETTE | — |
| JACQUELINE POMFRET KIRBY | — |
| JOHN MYERS | — |
| BELA SASTRY | — |
Taxation/Internal Revenue Code TAX
HR 4679 Stop Corporate Inversions Act of 2014, S2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACQUELINE POMFRET KIRBY | — |
| JOHN MYERS | — |
Copyright/Patent/Trademark CPT
S1720 - patent litigation reform. Issues Related to intellectual property practices in foreign countries and impact on US entities.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THERESA JOLIVETTE | — |
| JACQUELINE POMFRET KIRBY | — |
| BELA SASTRY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.